Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes

PloS One
Richard A AndersonAnne M Roussel

Abstract

Insulin resistance leads to memory impairment. Cinnamon (CN) improves peripheral insulin resistance but its effects in the brain are not known. Changes in behavior, insulin signaling and Alzheimer-associated mRNA expression in the brain were measured in male Wistar rats fed a high fat/high fructose (HF/HFr) diet to induce insulin resistance, with or without CN, for 12 weeks. There was a decrease in insulin sensitivity associated with the HF/HFr diet that was reversed by CN. The CN fed rats were more active in a Y maze test than rats fed the control and HF/HFr diets. The HF/HFr diet fed rats showed greater anxiety in an elevated plus maze test that was lessened by feeding CN. The HF/HFr diet also led to a down regulation of the mRNA coding for GLUT1 and GLUT3 that was reversed by CN in the hippocampus and cortex. There were increases in Insr, Irs1 and Irs2 mRNA in the hippocampus and cortex due to the HF/HFr diet that were not reversed by CN. Increased peripheral insulin sensitivity was also associated with increased glycogen synthase in both hippocampus and cortex in the control and HF/HFr diet animals fed CN. The HF/HFr diet induced increases in mRNA associated with Alzheimers including PTEN, Tau and amyloid precursor protein ...Continue Reading

References

Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·A P CruzF G Graeff
Mar 14, 2000·Physiology & Behavior·C R ParkS C Woods
Jul 11, 2001·Neuroscience and Biobehavioral Reviews·C R Park
Aug 17, 2001·Journal of the American College of Nutrition·K J Jarvill-TaylorD J Graves
Dec 7, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Nancy F Cruz, Gerald A Dienel
Apr 8, 2003·Current Pharmaceutical Design·Stephen C WoodsMichael W Schwartz
Nov 25, 2003·Diabetes Care·Alam KhanRichard A Anderson
Jan 8, 2004·Journal of Agricultural and Food Chemistry·Richard A AndersonDonald J Graves
Nov 5, 2005·Brain Research. Brain Research Reviews·Amina A Qutub, C Anthony Hunt
Apr 4, 2006·Journal of the American College of Nutrition·Harry G PreussRichard Anderson
Apr 22, 2006·Journal of Alzheimer's Disease : JAD·Nataniel Lester-CollSuzanne M de la Monte
Jun 24, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ariadne Legendre, Ruth B S Harris
Jun 27, 2007·Behavioral Neuroscience·G SoulisE Kitraki
Jul 31, 2007·Glia·Angus M Brown, Bruce R Ransom
Jan 5, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Scott M Grundy
Jan 22, 2008·Neurobiology of Aging·Onofre CombarrosDonald J Lehmann
May 27, 2008·Journal of the International Society of Sports Nutrition·Tim N ZiegenfussRichard A Anderson
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos
Mar 19, 2009·Brain : a Journal of Neurology·Mario A ParraSergio Della Sala
May 13, 2009·Journal of Alzheimer's Disease : JAD·Dylan W PetersonJohn Lew
Jun 12, 2009·Journal of the American Geriatrics Society·Wael K Al-DelaimyElizabeth Barrett-Connor
Jun 16, 2009·Biochemical and Biophysical Research Communications·Richard KillickSimon Lovestone
Sep 8, 2009·Journal of the American Board of Family Medicine : JABFM·Paul Crawford
Nov 4, 2009·Journal of Diabetes Science and Technology·Suzanne M de la Monte, Jack R Wands
Apr 28, 2010·Journal of Alzheimer's Disease : JAD·Vincenza FrisardiFrancesco Panza
Jun 2, 2010·Journal of Diabetes Science and Technology·Bolin QinRichard A Anderson
Jun 3, 2010·Archives of Biochemistry and Biophysics·K CouturierA M Roussel
Jun 5, 2010·Journal of Clinical and Experimental Neuropsychology·H BruehlA Convit

❮ Previous
Next ❯

Citations

Oct 29, 2014·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Hiranya PintanaSiriporn Chattipakorn
Feb 18, 2016·The Journal of Nutritional Biochemistry·Karine CouturierCécile Batandier
Jun 13, 2015·Physiology & Behavior·Zachary A Cordner, Kellie L K Tamashiro
Jun 26, 2015·Pharmacognosy Research·Pallavi Kawatra, Rathai Rajagopalan
Dec 7, 2017·International Journal of Experimental Pathology·Silvia GanchevaMaria Zhelyazkova-Savova
May 3, 2015·The Journal of Endocrinology·Barbara C FamSofianos Andrikopoulos
Oct 2, 2019·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Robert OseIris Bellinghausen
Jul 1, 2020·Fundamental & Clinical Pharmacology·Adel A GomaaMariam A Nicola
Sep 10, 2020·Journal of Molecular Neuroscience : MN·Doaa QubtyChaim G Pick
Nov 25, 2018·International Journal of Molecular Sciences·Rita Del Pinto, Claudio Ferri
Nov 21, 2020·Journal of Alzheimer's Disease : JAD·Julio A Flores-CuadraMaria B Carreira
Jul 10, 2019·European Journal of Pharmacology·Roksana SoukhakLariMaryam Moosavi
Jan 29, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Fernando Gomez-PinillaLuiz Fernando Freire Royes
Sep 2, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Julia FedotovaPeter Kruzliak
Apr 22, 2021·CNS & Neurological Disorders Drug Targets·Himanshi Varshney, Yasir Hasan Siddique

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
PCR

Software Mentioned

Statistica
Viewpoint
Statsoft

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2021 Meta ULC. All rights reserved